A New York Times health reporter explains what clinical trials are, why they are important and how they can help inform us.

Immuron Limited announced the submission of the Clinical Study Report for its Phase 2 clinical trial of Travelan® (IMM-124E) to the FDA, which demonstrated statistically significant immunological and ...

• In the Phase 1 portion of the CELC-G-201 clinical trial evaluating gedatolisib plusdarolutamide in men with metastatic castration resistant prostate cancer (“mCRPC”),the six-month radiographic ...

Clinical development programs for doxorubicin-containing microneedle array (D-MNA) and Teverelix, a next generation GnRH ...

View all available purchase options and get full access to this article. Supported by the National Health and Medical Research Council (NHMRC) Postgraduate Scholarship (APP2005294) to N.D.M, Emerging ...

SHELTON, CONNECTICUT / ACCESS Newswire / October 15, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), reports that an analyst research report was published on the Company that explains ...

Systems has optimized key device and treatment parameters including frequency, amplitude, electrode positioning, and duration ...

TORONTO, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative ...

University of Auckland researchers report that an 8-week, twice-weekly LSD microdosing regimen for major depressive disorder ...

Forte Biosciences Inc. ( ($FBRX) ) has released its Q3 earnings. Here is a breakdown of the information Forte Biosciences Inc. presented to its ...